Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.3900 (-1.46%) ($5.3000 - $5.4700) on Thu. Dec. 5, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.45% (three month average) | RSI | 49 | Latest Price | $5.3900(-1.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.4% a day on average for past five trading days. | Weekly Trend | CGEN declines -0.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(66%) ARKK(63%) XBI(63%) IBB(57%) IPO(55%) | Factors Impacting CGEN price | CGEN will decline at least -1.725% in a week (0% probabilities). VXX(-37%) VIXM(-33%) UUP(-11%) TLT(-4%) SHY(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.725% (StdDev 3.45%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
Resistance Level | $5.63 | 5 Day Moving Average | $5.63(-4.26%) | 10 Day Moving Average | $5.69(-5.27%) | 20 Day Moving Average | $5.63(-4.26%) | To recent high | -11.5% | To recent low | 7.6% | Market Cap | $446m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |